Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHRONIC MYELOGENOUS LEUKEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2964 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pittet, MJ; Speiser, DE; Valmori, D; Rimoldi, D; Lienard, D; Lejeune, F; Cerottini, JC; Romero, P
      Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Druker, BJ
      Current treatment approaches for chronic myelogenous leukemia

      CANCER JOURNAL
    3. Syme, RM; Bryan, TL; Gluck, S
      Dendritic cell-based therapy: A review focusing on antigenic selection

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    4. Hui, N; Le Marer, N
      alpha-2,6-sialylation regulation in CD34(+) progenitor cells in the human bone marrow and granulocyte colony-stimulating factor mobilization

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    5. Chiorean, EG; Miller, JS
      The biology of natural killer cells and implications for therapy of human disease

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    6. Porter, DL
      The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    7. Marijt, WAF; Falkenburg, JHF
      Specific T cell therapy in leukemia

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    8. Maki, G
      Ex vivo purging of stem cell autografts using cytotoxic cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    9. Meijerink, J; Mandigers, C; van de Locht, L; Tonnissen, E; Goodsaid, F; Raemaekers, J
      A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR

      JOURNAL OF MOLECULAR DIAGNOSTICS
    10. Rivas, C; Miller, ARM; Collado, M; Lam, EWF; Apperley, JF; Melo, JV
      BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

      MOLECULAR THERAPY
    11. Muller, L; Provenzani, C; Pawelec, G
      Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures

      JOURNAL OF IMMUNOTHERAPY
    12. Chase, A; Huntly, BJP; Cross, NCP
      Cytogenetics of chronic myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    13. Hall, GW
      Childhood myeloid leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    14. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    15. Rousseau, RF; Bollard, CM; Heslop, HE
      Gene therapy for paediatric leukaemia

      EXPERT OPINION ON BIOLOGICAL THERAPY
    16. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    17. Stark, G; O'Brien, SG
      An update on chronic myeloid leukaemia

      CLINICAL MEDICINE
    18. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
      Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells

      CYTOTHERAPY
    19. Szer, J; Lieschke, GJ
      Small molecule: large hopes

      INTERNAL MEDICINE JOURNAL
    20. Grigg, A; Kannan, K; Schwarer, AP; Spencer, A; Szer, J
      Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation

      INTERNAL MEDICINE JOURNAL
    21. Schanz, U
      Allogeneic haematopoietic stem cell transplantation with reduced intensityconditioning regimens ("minitransplants")

      SWISS MEDICAL WEEKLY
    22. Maru, Y; Bergmann, E; Coin, F; Egly, JM; Shibuya, M
      TFIIH functions are altered by the P210BCR-ABL oncoprotein produced on thePhiladelphia chromosome

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    23. Krystal, GW
      Mechanisms of resistance to imatinib (ST1571) and prospects for combination with conventional, chemotherapeutic agents

      DRUG RESISTANCE UPDATES
    24. Weisberg, E; Griffin, JD
      Mechanisms of resistance imatinib (ST1571) in preclinical models and in leukemia patients

      DRUG RESISTANCE UPDATES
    25. Radojkovic, M; Ristic, S; Colovic, M; Todoric, B; Krtolica, K
      Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia

      MEDICAL ONCOLOGY
    26. Sangfelt, O; Strander, H
      Apoptosis and cell growth inhibition as antitumor effector functions of interferons

      MEDICAL ONCOLOGY
    27. Russell, AI; Lawson, WA; Haskard, DO
      Potential new therapeutic options in Behcet's syndrome

      BIODRUGS
    28. Benthin, M; Dallmann, I; Atzpodien, J
      13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    29. Antin, JH; Childs, R; Filipovich, AH; Giralt, S; Mackinnon, S; Spitzer, T; Weisdorf, D
      Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001Tandem Meetings

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    30. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    31. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
      Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    32. Patterson, AE; Korngold, R
      Infusion of select leukemia-reactive TCR V beta(+) T cells provides graft-versus leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    33. Ho, VT; Weller, E; Lee, SJ; Alyea, EP; Antin, JH; Soiffer, RJ
      Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    34. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    35. Verneris, MR; Ito, M; Baker, E; Arshi, A; Negrin, RS; Shizuru, JA
      Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    36. Carlens, S; Remberger, M; Aschan, J; Ringden, O
      The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    37. Bartolo, C; Viswanatha, DS
      Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications

      JOURNAL OF CLINICAL LIGAND ASSAY
    38. Hartwig, UF; Keller, U; Huber, C; Peschel, C
      Regulation of hematopoietic growth factor production by genetically modified human bone marrow stromal cells expressing interleukin-1 beta antisense RNA

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    39. Efferth, T; Futscher, BW; Osieka, R
      5-azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs

      BLOOD CELLS MOLECULES AND DISEASES
    40. Van Etten, RA
      Retroviral transduction models of Ph+ leukemia: Advantages and limitationsfor modeling human hematological malignancies in mice

      BLOOD CELLS MOLECULES AND DISEASES
    41. Honda, H; Hirai, H
      Model mice for BCR/ABL-positive leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    42. Ratain, MJ; Relling, MV
      Gazing into a crystal ball-cancer therapy in the post-genomic era

      NATURE MEDICINE
    43. Bornhauser, M; Thiede, C; Platzbecker, U; Jenke, A; Helwig, A; Plettig, R; Freiberg-Richter, J; Rollig, C; Geissler, G; Lutterbeck, K; Oelschlagel, U; Ehninger, G
      Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients

      CLINICAL CANCER RESEARCH
    44. Nimmanapalli, R; Porosnicu, M; Nguyen, D; Worthington, E; O'Bryan, E; Perkins, C; Bhalla, K
      Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

      CLINICAL CANCER RESEARCH
    45. Karlic, H; Louda, N; Pfeilstocker, M; Keil, F; Lohninger, A; Pittermann, E; Paukovits, J
      Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1 alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML)

      STEM CELLS
    46. Cutler, C; Antin, JH
      Peripheral blood stem cells for allogeneic transplantation: A review

      STEM CELLS
    47. Anasetti, C; Petersdorf, EW; Martin, PJ; Woolfrey, A; Hansen, JA
      Trends in transplantation of hematopoietic stem cells from unrelated donors

      CURRENT OPINION IN HEMATOLOGY
    48. Peggs, KS; Mackinnon, S
      Cellular therapy: donor lymphocyte infusion

      CURRENT OPINION IN HEMATOLOGY
    49. Van Etten, RA
      Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

      CURRENT OPINION IN HEMATOLOGY
    50. Fioretos, T; Panagopoulos, I; Lassen, C; Swedin, A; Billstrom, R; Isaksson, M; Strombeck, B; Olofsson, T; Mitelman, F; Johansson, B
      Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL

      GENES CHROMOSOMES & CANCER
    51. Jeffs, AR; Wells, E; Morris, CM
      Nonrandom distribution of interspersed repeat elements in the BCR and ABLIgenes and its relation to breakpoint cluster regions

      GENES CHROMOSOMES & CANCER
    52. Metzke-Heidemann, S; Harder, L; Gesk, S; Schoch, R; Jenisch, S; Grote, W; Siebert, R; Schlegelberger, B
      Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia

      GENES CHROMOSOMES & CANCER
    53. Shteper, P; Ben-Yehuda, D
      Molecular evolution of chronic myeloid leukaemia

      SEMINARS IN CANCER BIOLOGY
    54. Shannon, KM; Le Beau, MM; Largaespada, DA; Killeen, N
      Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse

      SEMINARS IN CANCER BIOLOGY
    55. Gunzer, M; Janich, S; Varga, G; Grabbe, S
      Dendritic cells and tumor immunity

      SEMINARS IN IMMUNOLOGY
    56. Thiele, J; Kvasnicka, HM
      Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    57. Clark, RE; Christmas, SE
      BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    58. Kitzis, A; Brizard, F; Dascalescu, C; Chomel, JC; Guilhot, F; Brizard, A
      Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission

      LEUKEMIA & LYMPHOMA
    59. Vey, N; Balatzentko, G; LaFage, M; Sainty, D; Bouabdallah, R; Chabannon, C; Blaise, D; Gastaut, JA; Gabert, J
      Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    60. Perez-Losada, J; Gutierrez-Cianca, N; Sanchez-Garcia, I
      Philadelphia-positive B-Cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell

      LEUKEMIA & LYMPHOMA
    61. Fujii, S; Shimizu, K; Fujimoto, K; Kiyokawa, T; Tsukamoto, A; Sanada, I; Kawano, F
      Treatment of post-transplanted, relapsed patients with hematological malignancies by infusion of HLA-matched, allogeneic-dendritic cells (DCs) pulsedwith irradiated tumor cells and primed T cells

      LEUKEMIA & LYMPHOMA
    62. Ahmed, M; Dusanter-Fourt, I; Dugray, A; Dubrez, L; Novault, S; Bonnet, ML; Gisselbrecht, S; Varet, B; Solary, E; Vainchenker, W; Turhan, AG
      BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressinga carboxyl-terminal truncated Stat5

      LEUKEMIA & LYMPHOMA
    63. Kimura, S; Kuroda, J; Akaogi, T; Hayashi, H; Kobayashi, Y; Kondo, M
      Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis - Behcet's syndrome

      LEUKEMIA & LYMPHOMA
    64. Giles, FJ; Kantarjian, H; O'Brien, S; Rios, MB; Cortes, J; Beran, M; Koller, C; Keating, M; Talpaz, M
      Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with Philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase

      LEUKEMIA & LYMPHOMA
    65. Shiratsuchi, M; Muta, K; Minami, R; Motomura, S; Suehiro, Y; Abe, Y; Shiokawa, S; Umemura, T; Fukui, T; Nishimura, J; Nawata, H
      Aberrant BCR-ABL transcript with intronic insertion in a patient with Philadelphia chromosome-positive chronic myeloid leukemia: Implications for disease progression

      LEUKEMIA & LYMPHOMA
    66. Vey, N; Camerlo, J; Xerri, L; Petit, N; Dermeche, S; Maraninchi, D
      Simultaneous occurrence of Kaposi's Sarcoma and chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    67. Buckstein, RJ; Rimrie, K; Pennell, N; Spaner, D; Hewitt, K; Berinstein, NL
      Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab

      LEUKEMIA & LYMPHOMA
    68. Nadal, E; Cervantes, F; Rosinol, L; Talarn, C; Montserrat, E
      Hypercalcemia as the presenting feature of T-cell lymphoid blast crisis ofph-positive chronic myeloid leukemia

      LEUKEMIA & LYMPHOMA
    69. Wirt, DP; Giles, FJ; Oken, MM; Solal-Celigny, P; Beck, JR
      Cost-effectiveness of interferon alfa-2b added to chemotherapy for high-tumor-burden follicular non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    70. Weekes, CD; Kuszynski, CA; Sharp, JG
      VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells

      LEUKEMIA & LYMPHOMA
    71. Otten, HG; Van Dyk, AMC; Verdonck, LF
      Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cells

      LEUKEMIA & LYMPHOMA
    72. Claxton, DF; McMannis, J; Champlin, R; Choudhury, A
      Therapeutic potential of leukemia-derived dendritic cells: Preclinical andclinical progress

      CRITICAL REVIEWS IN IMMUNOLOGY
    73. Koski, GK; Lyakh, LA; Cohen, PA; Rice, NR
      CD14(+) monocytes as dendritic cell precursors: Diverse maturation-inducing pathways lead to common activation of NF-kappa B/RelB

      CRITICAL REVIEWS IN IMMUNOLOGY
    74. Childs, RW
      Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma

      CRITICAL REVIEWS IN IMMUNOLOGY
    75. Gebhart, E; Rosler, W; Gramatzki, M; Trautmann, U
      FISH monitoring of 100 courses of human leukemias: The cytogenetic viewpoint

      INTERNATIONAL JOURNAL OF ONCOLOGY
    76. Nadav, L; Katz, BZ
      The molecular effects of oncogenesis on cell-extracellular matrix adhesion(Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    77. Saitoh, T; Hirai, M; Katoh, M
      Molecular cloning and characterization of human Frizzled-5 gene on chromosome 2q33.3-q34 region

      INTERNATIONAL JOURNAL OF ONCOLOGY
    78. Granel, B; Serratrice, J; Bouabdallah, R; Pache, X; Weiller-Merli, C; Swiader, L; Aquaron, R; Disdier, P; Nordmann, Y; Weiller, PJ
      Atypical porphyria cutanea tarda in a patient with chronic myelogenous leukemia

      DERMATOLOGY
    79. Simpson, E; Scott, D; James, E; Lombardi, G; Cwynarski, K; Dazzi, F; Millrain, M; Dyson, PJ
      Minor H antigens: genes and peptides

      EUROPEAN JOURNAL OF IMMUNOGENETICS
    80. Mughal, TI; Goldman, JM
      Chronic myeloid leukaemia: STI 571 magnifies the therapeutic dilemma

      EUROPEAN JOURNAL OF CANCER
    81. Tomita, N; Motomura, S; Ishigatsubo, Y
      Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia

      ANTI-CANCER DRUGS
    82. Natarajan, S; Williamson, D; Grey, J; Harding, KG; Cooper, RA
      Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey

      JOURNAL OF DERMATOLOGICAL TREATMENT
    83. Feller, SM
      Crk family adaptors - signalling complex formation and biological roles

      ONCOGENE
    84. Xie, SH; Wang, Y; Liu, JX; Sun, T; Wilson, MB; Smithgall, TE; Arlinghaus, RB
      Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation

      ONCOGENE
    85. Hoover, RR; Gerlach, MJ; Koh, EY; Daley, GQ
      Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells

      ONCOGENE
    86. Wong, S; Witte, ON
      Modeling Philadelphia chromosome positive leukemias

      ONCOGENE
    87. Yu, HH; Zisch, AH; Dodelet, VC; Pasquale, EB
      Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor

      ONCOGENE
    88. Miyoshi-Akiyama, T; Aleman, LM; Smith, JM; Adler, CE; Mayer, BJ
      Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor

      ONCOGENE
    89. Peters, DG; Klucher, KM; Perlingeiro, RCR; Dessain, SK; Koh, EY; Daley, GQ
      Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformedhematopoietic cell line that induces leukemia in mice

      ONCOGENE
    90. Lin, F; Monaco, G; Sun, T; Liu, JX; Lin, H; Stephens, C; Belmont, J; Arlinghaus, RB
      BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model

      ONCOGENE
    91. Tossing, G
      New developments in interferon therapy

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    92. Hernandez-Boluda, JC; Cervantes, F; Alvarez, A; Costa, D; Montserrat, E
      Single-agent therapy with oral mercaptopurine for nonlymphoid blast crisisof chronic myeloid leukemia

      ANNALS OF HEMATOLOGY
    93. Renner, C; Kubuschok, B; Trumper, L; Pfreundschuh, M
      Clinical approaches to vaccination in oncology

      ANNALS OF HEMATOLOGY
    94. Fruehauf, S; Steiger, S; Topaly, J; Ho, AD
      Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    95. Kroger, N; Zabelina, T; Kruger, W; Renges, H; Stute, N; Durken, M; von Finkenstein, FG; Erttmann, R; Kabisch, H; Schafhausen, P; Jaburg, N; Loliger, C; Zander, AR
      Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors

      ANNALS OF HEMATOLOGY
    96. Dreger, P; Schmitz, N
      Allogeneic transplantation of blood stem cells: Coming of age?

      ANNALS OF HEMATOLOGY
    97. Platzbecker, U; Thiede, C; Freiberg-Richter, J; Helwig, A; Mohr, B; Prange, G; Fussel, M; Kohler, T; Ehninger, G; Bornhauser, M
      Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF

      ANNALS OF HEMATOLOGY
    98. Sick, C; Schultheis, B; Pasternak, G; Kottke, I; Horner, S; Heissig, B; Hehlmann, R
      Predominantly BCR-ABL negative myeloid precursors in interferon-alpha treated chronic myelogenous leukemia: a follow-up study of peripheral blood colony-forming cells with fluorescence in situ hybridization

      ANNALS OF HEMATOLOGY
    99. Kahl, C; Pelz, AF; Bartsch, R; Jentsch-Ullrich, K; Bruckner, R; Fostitsch, HP; Franke, A
      Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes

      ANNALS OF HEMATOLOGY
    100. Badid, C; McGregor, B; Faivre, JM; Guerard, A; Juillard, L; Fouque, D; Laville, M
      Renal thrombotic microangiopathy induced by interferon-alpha

      NEPHROLOGY DIALYSIS TRANSPLANTATION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 13:24:13